| Literature DB >> 26175694 |
Jordan A Tharp1, Carter Wendelken2, Carol A Mathews3, Elysa J Marco4, Herbert Schreier5, Silvia A Bunge6.
Abstract
Some individuals with Tourette syndrome (TS) have severe motoric and vocal tics that interfere with all aspects of their lives, while others have mild tics that pose few problems. We hypothesize that observed tic severity reflects a combination of factors, including the degree to which dopaminergic (DA) and/or noradrenergic (NE) neurotransmitter systems have been affected by the disorder, and the degree to which the child can exert cognitive control to suppress unwanted tics. To explore these hypotheses, we collected behavioral and eyetracking data from 26 patients with TS and 26 controls between ages 7 and 14, both at rest and while they performed a test of cognitive control. To our knowledge, this is the first study to use eyetracking measures in patients with TS. We measured spontaneous eyeblink rate as well as pupil diameter, which have been linked, respectively, to DA and NE levels in the central nervous system. Here, we report a number of key findings that held when we restricted analyses to unmedicated patients. First, patients' accuracy on our test of cognitive control accounted for fully 50% of the variance in parentally reported tic severity. Second, patients exhibited elevated spontaneous eyeblink rates compared to controls, both during task performance and at rest, consistent with heightened DA transmission. Third, although neither task-evoked pupil dilation nor resting pupil diameter differed between TS patients and controls, pupil diameter was positively related to parentally reported anxiety levels in patients, suggesting heightened NE transmission in patients with comorbid anxiety. Thus, with the behavioral and eyetracking data gathered from a single task, we can gather objective data that are related both to tic severity and anxiety levels in pediatric patients with TS, and that likely reflect patients' underlying neurochemical disturbances.Entities:
Keywords: Tourette syndrome; anxiety; cognitive control; dopamine; executive functions; eye-blink rate; norepinephrine; pupillometry
Year: 2015 PMID: 26175694 PMCID: PMC4484341 DOI: 10.3389/fpsyt.2015.00095
Source DB: PubMed Journal: Front Psychiatry ISSN: 1664-0640 Impact factor: 4.157
Figure 1Four sample trials of the Nemo task, showing the sequence of stimuli presented on each trial. The condition labels and the indicated correct responses correspond to the rule “Blue is left, red is right.”
Group differences in demographics and questionnaires, considering all TS patients as well as unmedicated TS patients only.
| Control | All TS | Unmed TS | |||
|---|---|---|---|---|---|
| Mean (SD) | Mean (SD) | Mean (SD) | |||
| 26 | 26 | n/a | 18 | n/a | |
| 21 | 19 | n/a | 13 | n/a | |
| % Male | 54.4 | 61.5 | 1.4, 17 | 52.6 | |
| Age | 10.5 (2) | 10.4 (2) | 10.1 (2) | ||
| Pubertal development | 11.9 (4) | 12.3 (4) | 12.8 (4) | ||
| SES | 7.6 (1) | 7.2 (2) | 1.0, 0.35 | 6.9 (2) | 1.3, 0.19 |
| Digit span score | 10.5 (2) | 9.3 | 1.7, 0.11 | 9.6 (2) | 1.1, 0.27 |
| 121.1 (14) | 112.5 (13) | 112.0 (13) | |||
| 49.6 (10) | 60.2 (12) | 59.1 (13) | |||
| 48.8 (13) | 59.2 (11) | 58.2 (12) | |||
| 51.1 (8) | 60.7 (14) | 61.6 (16) | |||
| 0 | 6.3 (8) | 4.7 (8) | |||
| 0 | 21.2 (13) | 17.7 (7) | |||
| MASC | 64.4 (18) | 73.1 (14) | −1.7, 0.11 | 74.6 (11) | −1.9, 0.06 |
SES, Socioeconomic Status; WASI, Wechsler Abbreviated Scale of Intelligence; BRIEF, Behavior Rating Inventory of Executive Function (global measure); CBCL, Child Behavior Checklist; Conners’ ADHD, Conners’ ADHD Index; CY-BOCS, Children’s Yale–Brown Obsessive–Compulsive Scale; YGTSS, Yale Global Tic Severity Scale; MASC, Multidimensional Anxiety Scale for Children; n/a, not applicable. T-tests are reported for all TS patients vs. controls, as well as for unmedicated TS patients vs. controls. Significant group differences are featured in bolded text. Statistics are not reported for t-values <1.
Figure 2Performance on Mixed blocks of the Nemo task. (A) Patients exhibited a larger decrement in performance on Incongruent vs. Congruent trials than did controls. (B) Controls demonstrated increased response times for Incongruent relative to Congruent trials. (C) Scatter-plot showing the relationship between tic severity (YGTSS severity index) and accuracy in unmedicated TS patients. (D) Scatter-plot showing the relationship between tic severity and average response times in unmedicated TS patients. Error bars indicate within-subjects standard error. Asterisks denote p < 0.05.
Figure 3(A) Observed rate of gaps in the eyetracking data, at fixed intervals, for patients and controls. Values on the x-axis give the lower bound for each interval; the left-most interval includes gaps between 100 and 200 ms in duration, while the rightmost interval includes gaps between 1500 and 1600 ms. The shaded box indicates gaps that were considered to be valid blinks. Gaps of <100 ms were excluded from this graph. (B) Average blink rate during task blocks, in controls, unmedicated TS patients, and all TS patients. (C) Average blink rate during the 30-s baseline fixation period, for each group. Error bars indicate standard error of the mean. Asterisks denote p < 0.05.
Figure 4(A) Average pupil diameter timecourses, for all TS patients and for controls. Pupil diameter was averaged across all correct mixed-block trials, and then averaged across participants. Error bars (shading) depict standard error of the mean, across participants. The appearance of the cue stimulus and probe stimulus are indicated at the bottom of the graph. (B) Scatter-plot of the relationship between anxiety (MASC Anxiety score) and average pupil diameter across unmedicated TS patients.